HRA004543
Title:
pan-cancer gene variations
Release date:
2024-04-28
Description:
germline variants and somatic mutations detected in leukocytes and cfDNA of more than 10,000 patients with cancer from 27 cancer types. It bears great promise to serve as a valuable resource for cancer research.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Cohort Study
Disease name:
cancer
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
Chinese pancancer study
Contact person:
He Ji
Email:
he.ji@genecast.com.cn
Description:
Based on Genecast cancer panel detecting system, we collected a series of cancer sample including FFPE, cfDAN and BC for pancancer study
Individuals & samples
Submitter:   He Ji / he.ji@genecast.com.cn
Organization:   Company Name: Genecast Biotechnology Co., Ltd
Submission date:   2023-04-23
Requests:   4